An experimental antibiotic, zosurabalpin, to fight a deadly superbug has entered the final human trials. Currently, no new ...

A new antibiotic that has the potential to save millions of lives has entered its last phase of human testing. Swiss ...

Swiss drugmaker Roche (ROG.S), said on Monday it would advance testing of an antibiotic against a common drug-resistant ...

Roche (RHHBY) is planning to move a new antibiotic into late stage clinical trials after early studies showed it had ...

Hundreds of patients will be recruited for a major trial of what could be the first new antibiotic of its kind for 50 years.

A new antibiotic that could treat a common ‘superbug’ is to be tested on patients. The drug Zosurabalpin, is being developed ...

A new study has revealed that certain foods that can help you eliminate per- and polyfluoroalkyl substances (PFAS).

The most common cause of green nail syndrome is the superbug bacterium Pseudomonas aeruginosa. Famed for hard-to-treat ...

Gaza faces severe medical supply shortages; Australia's Healthscope seeks buyers amid financial woes; Roche advances a ...

AbbVie has claimed FDA approval for Emblaveo, a new antibiotic product to treat complicated intra-abdominal infections (cIAI), including those caused by Gram-negative bacteria that represent a ...

Roche is moving its novel antibiotic zosurabalpin into phase 3 testing for carbapenem-resistant Acinetobacter baumannii (CRAB), a 'superbug' that is considered an 'urgent threat' by the CDC, in what ...